Familial aggregation of melanoma risks in a large population-based sample of melanoma cases

Cancer Causes and Control

Volumn 15, Issue 9, 2004, Pages 957-965

  Begg, Colin B ^a   Hummer, Amanda ^a   Mujumdar, Urvi ^a   Armstrong, Bruce K ^b   Kricker, Anne ^b   Marrett, Loraine D ^c   Millikan, Robert C ^d   Gruber, Stephen B ^e   Anton Culver, Hoda ^f   Klotz, Judith B ^g   Zanetti, Roberto ^h   Gallagher, Richard P ⁱ   Dwyer, Terence ^j   Rebbeck, Timothy R ^k   Berwick, Marrianne R ^l  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CANCER CARE ONTARIO   (Canada)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^h CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁱ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^j UNIVERSITY OF TASMANIA   (Australia)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY OF NEW MEXICO   (United States)

more..

Author keywords

analyses; cohort; melanoma; risk factors

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANADA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; EYE COLOR; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HAIR COLOR; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RELATIVE; SEX RATIO; SKIN SENSITIVITY; UNITED STATES;

EID: 10844233950     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10552-004-2474-1     Document Type: Article

References (47)

1. Armstrong BK, Kricker A (1994) Cutaneous melanoma. In: Cancer Surveys Voume 19: Trends in Cancer Incidence and Mortality. Imperial Cancer Research Fund, London.
2. Boyle P, Maisonneuve P, Dore JF (1995) Epidemiology of malignant melanoma. Br Med Bull 51: 523-547.
3. Elwood JM (1993) Recent developments in melanoma epidemiology, 1993. Melanoma Res 3: 149-156.
4. Bliss JM, Ford D, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 62: 367-376.
5. Kamb A, Gruis NA, Weaver-Feldhous J, et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
6. Holland EA, Beaton SC, Becker TM, et al. (1995) Analysis of the p16 gene, CDKN2, in 17 Australian kindreds. Oncogene 11: 2289-2294.
7. Goldstein AM, Tucker MA (2001) Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol 137: 1493-1496.
8. Saunders CL, Begg CB (2003) Kin-cohort evaluation of relative risks of genetic variants. Genet Epidemiol 24: 220-229.
9. Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94: 1221-1226.
10. Fitzpatrick TB (1975) Soleil et peau. J Med Esthet 2: 33.
11. Ries LAG, Eisner MP, Kosary CL, et al. eds. (2002) SEER Cancer Statistics Review 1973-1999, Bethesda, MD: National Cancer Institute. Also available from: URL: http://seer.cancer.gov/csr/1973_1999.
12. Stata® (2001) Reference Manual, Release 7, College Station, Texas: Stata Press.
13. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG (1994) Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 140: 961-973.
14. Ford D, Bliss JM, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 62: 377-381.
15. Risch N (1990) Linkage strategies for genetically complex traits: I. multilocus models. Am J Hum Genet 46: 222-228.
16. Hemminki K, Zhang H, Czene K (2003) Familial and attributable risks in cutaneous melanoma: effects of proband and age. J Invest Dermatol 120: 217-223.
17. Begg CB (2001) The search for cancer risk factors: when can we stop looking? Am J Public Health 91: 360-364.
18. Swerdlow AJ, Green A (1987) Melanocytic naevi and melanoma: an epidemiologic perspective. Br J Dermatol 117: 137-146.
19. Swerdlow AJ, English J, Mackie RM, et al. (1986) Benign melanocytic naevi as a risk factor for melanoma. Br Med J 292: 1555-1559.
20. Holly EA, Kelly SW, Shpall SN, Chiu SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459-468.
21. Roush GC, Norlund JJ, Forget B, Gruber SB, Kirkwood JM (1988) Independence of dysplastic nevi from total nevi in determining risk for non-familial melanoma. Prev Med 17: 273-279.
22. Grob JJ, Gouvernet J, Aymar D, et al. (1990) Count of benign melanocytic nevi as a major indicator of risk for non-familial nodular and superficial spreading melanoma. Cancer 66: 387-395.
23. Augustsson A, Stierner U, Rosdahl I, Suurkula M (1990) Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in Swedish population. Acta Derm Verereol 71: 518-524.
24. Kruger S, Garke C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfaros C (1992) Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. J Am Acad Dermatol 26: 920-926.
25. Bataille V, Newton Bishop JA, Sasieni P, et al. (1996) Risk of cutaneous melanoma in relation to the numbers, types and sitzes of naevi: a case-control study. Br J Cancer 73: 1605-1611.
26. Tucker MA, Halpern A, Holly EA, et al. (1997) Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 277: 1439-1444.
27. Brogelli L, DeGiorgi V, Bini F, Giannotti B (1991) Melanocytic naevi: clinical features and correlation with the phenotype in healthy young males in Italy. Br J Dermatol 125: 349-352.
28. Dennis L, White E, Lee JAH, Kristal A, McKnight B, Odland P (1996) Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 143: 248-256.
29. Dennis LK, White E, McKnight B, Kristal A, Lee JAH, Odland P (1996) Nevi and migration within the United States and Canada: a population-based cross-sectional study. Cancer Causes Control 7: 464-473.
30. Carli P, Naldi L, Lovati S, LaVecchia C (1996) The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer 101: 375-379.
31. Dulon M, Weichenthal M, Blettner M, et al. (2002) Sun exposure and number of nevi in 5- to 6-year old European children. J Clin Epidemiol 55: 1075-1081.
32. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood. Cancer 97: 628-638.
33. Wachsmuth RC, Gaut RM, Barrett JH, et al. (2001) Heritability and gene-environment interactions for melanocytic nevus density examined in a UK adolescent twin study. J Invest Dermatol 117: 348-352.
34. Zhu G, Duffy DL, Eldridge A, et al. (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65: 483-492.
35. Foon PW, Scheuner MT, Paterson-Oshlke KL, Gwinn M, Faucett A, Khoury MJ (2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4: 304-320.
36. Feightner JW (1994) Prevention of skin cancer. In: Canadian Task Force on Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, pp. 850-859.
37. http://www.health.gov.au/nhmrc/publications/pdf/cp68.pdf
38. US Preventive Services Task Force (2001) Screening for skin cancer: recommendations and rationale. Am J Prev Med 20: 44-46.
39. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BJ (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94: 1537-1545.
40. Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24: 190-198.
41. Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6: 313-317.
42. Marrett LD, Nguyen HL, Armstrong BK (2001) Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 92: 457-462.
43. Gaudette LA, Gao RN (1998) Changing trends in melanoma incidence and mortality. Health Rep 10: 29-41.
44. Buettner PG, Garbe C (2000) Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol 151: 72-77.
45. Harrison SL, Buettner PG, MacLemmon R, Kelly JW, Rivers JK (2002) How good are parents at assessing melanocytic nevi on their children? A study comparing parental counts, dermatologist counts, and counts obtained from photographs. Am J Epidemiol 155: 1128-1136.
46. Bain C, Colditz GA, Willett WC, et al. (1998) Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 127: 703-712.
47. English DR, Armstrong BK (1994) Melanocytic nevi in children. II. Observer variation in counting nevi. Am J Epidemiol 139: 402-407.